Navigation Links
FDA Approves Cefepime for Use In B. Braun's DUPLEX(R) System
Date:5/11/2010

BETHLEHEM, Pa., May 11 /PRNewswire/ -- The U.S. Food and Drug Administration recently approved an application that permits B. Braun Medical Inc. (B. Braun) to deliver FDA-approved 1g and 2g Cefepime for Injection USP and Dextrose Injection USP in B. Braun's DUPLEX® Drug Delivery System.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO )

Used in hospitals and healthcare centers to treat a wide variety of bacterial infections, Cefepime should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in the treatment of pneumonia, uncomplicated and complicated urinary tract infections, empiric therapy for febrile neutropenic patients, uncomplicated skin and skin structure infections, and complicated intra-abdominal infections. The availability of 1g and 2g Cefepime in the DUPLEX® System will mean faster, safer and accurate administration of Cefepime to patients as it can be stored ready-to-use in a container wherever and whenever it is needed.

"Making 1g and 2g Cefepime available to healthcare workers in B. Braun's DUPLEX® Drug Delivery System gives them another weapon to combat challenging infections with speed, safety and accuracy," said Rob Albert, Vice President of Marketing for B. Braun Medical I
'/>"/>

SOURCE B. Braun Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
2. FDA Approves New Combination Product Oral Contraceptive
3. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
4. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
5. FDA Approves New Device for Adults with Severe and Persistent Asthma
6. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
7. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
8. FDA Approves First Totally Implanted Hearing System
9. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
10. FDA Approves Name Change for Heartburn Drug Kapidex
11. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 The European ... defines and segments the concerned market in Europe ... non-invasive & minimally invasive cardiac output monitoring devices market in ... in 2014 and is estimated to grow to $89.8 million ... 2019. Browse through the TOC of European non-invasive ...
(Date:3/2/2015)... 2, 2015 Cure SMA recently announced a new ... Research (CALIBR). This funding is an extension of a spinal ... $700,000 Cure SMA grant to Dr. Peter G. Schultz ... of Small Molecules that Increase SMN2 Levels for ... neuron (SMN) protein is critical to the function of the ...
(Date:3/2/2015)... GLENWOOD, Ill. , March 2, 2015  Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... today announced it will release financial results for the ... Monday, March 9, 2015. The Company ... Tuesday, March 10, 2015 at 9:00 a.m. Central Time ...
Breaking Medicine Technology:European Non-Invasive & Minimally Invasive Cardiac Output Monitoring Devices Market is Expected to Reach $89.8 Million by 2019, at a CAGR of 4.2% from 2014 to 2019 2European Non-Invasive & Minimally Invasive Cardiac Output Monitoring Devices Market is Expected to Reach $89.8 Million by 2019, at a CAGR of 4.2% from 2014 to 2019 3Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3Landauer, Inc. Announces Date and Time for Announcement of Fiscal First Quarter 2015 Results and Conference Call 2
... Genprex, Inc. announced today that it will be presenting at ... San Francisco.   Greg Heinlein , Chief Operating and Financial Officer, ... Forum , on October 25 starting at 11 a.m. PDT in ... be made available on the company,s website under the News & ...
... CINCINNATI, Oct. 20, 2011 Prasco Laboratories , announced ... Eli Lilly and Company (NYSE: LLY ... Tablets and ZYPREXA® ZYDIS (olanzapine) Orally Disintegrating Tablets, in the ... products upon the first ANDA entrant into the market.  Prasco ...
Cached Medicine Technology:Genprex Presenting at 10th Annual BIO Investor Forum 2Prasco® Selected as Eli Lilly and Company's Authorized Generics Partner 2
(Date:3/3/2015)... March 03, 2015 The Data 360 ... at the Ford Conference Center, Dearborn, MI, on March 5, ... Inc., is a featured speaker. He is known internationally as ... , These designations were earned due to years of ... commercially-available NoSQL DB, released over 10 years ago. Subsequent developments ...
(Date:3/3/2015)... 03, 2015 Sponsors of Medicare Advantage ... abundance of significant proposed changes to sift through as ... 2016 Call Letter released Feb. 20. The potential pay ... vary considerably with the type and location of the ... and comment on them before CMS issues the final ...
(Date:3/3/2015)... March 03, 2015 When a lifeguard is on ... Comfort is more than just loose clothing. For a ... to the public too much when the guard prefers to cover ... morning or the evening and wearing the clothing that fits correctly. ... during a shift, it is imperative that the guard stays warm ...
(Date:3/3/2015)... HealthCarePoint (HCP) , the Texas-based ... that it has completed development of the BlueCloud™ ... Consortium (CDISC). HCP will continue to provide in-kind ... and certifications globally. HCP’s in-kind services will also ... well as development of dynamic identification for country-specific ...
(Date:3/3/2015)... Omaha, NE (PRWEB) March 03, 2015 ... healthcare staffing, including Physician jobs, has announced that it ... Fair to be held Tuesday, March 17, 2015 in ... with an opportunity to meet job-seeking residents and fellows ... Medical’s physician division will be available to ...
Breaking Medicine News(10 mins):Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 2Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 3Health News:Scientel® to Present at Data 360 Big Data Healthcare Conference, March 5, 2015, Dearborn, MI 4Health News:March 12 Webinar to Analyze Implications of CMS’s ’45-Day Notice’ and 2016 Call Letter for MA and Part D Plans 2Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 2Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 3Health News:New Lifeguard Pants Introduced for those Colder Lifeguarding Days 4Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 2Health News:HealthCarePoint Completes CDISC BlueCloud Transnational Commerce Through In-kind Donations 3
... who take commonly prescribed drugs for osteoporosis known as bisphosphonates ... of certain kinds of fractures of their thigh bone, a ... hip fractures. And, since the overall risk of thigh bone ... risk for hip and other osteoporosis-related fractures should not stop ...
... Huggins HealthDay Reporter , TUESDAY, Feb. 22 (HealthDay ... looks good on a resume when you,re young, it may ... A new study finds that seniors who speak three, four ... memory than their peers. Most people already know the ...
... February 22, 2011 (BRONX, NY) In an ... at Albert Einstein College of Medicine of ... improve survival after life-threatening blood loss. Nanoparticles containing nitric ... where they helped maintain blood circulation and protect vital ...
... Feb. 22, 2011 Getting more exercise, spending time ... can be as effective as drugs or counseling in ... anxiety, according to a UC Irvine study. In ... human behavior, philosophy and anthropology, as well as adjunct ...
... Reporter , TUESDAY, Feb. 22 (HealthDay News) -- Men and ... of ischemic stroke, which typically occurs when blood flow to ... within blood vessels, a new Danish study contends. In ... triglyceride fats than it is for cholesterol, even though cholesterol ...
... LANSING, Mich. Want to keep your boss happy? Smile ... Smile like you mean it. A new study led ... who fake smile throughout the day worsen their mood and ... a result of cultivating positive thoughts such as a ...
Cached Medicine News:Health News:Study links long-term use of osteoporosis drugs to unusual fractures 2Health News:Speaking Several Languages Might Protect Memory 2Health News:Speaking Several Languages Might Protect Memory 3Health News:Nanoparticles increase survival after blood loss 2Health News:Therapeutic lifestyle changes as useful as drugs in improving mental health 2Health News:High Triglyceride Levels Linked to Increased Stroke Risk: Study 2Health News:High Triglyceride Levels Linked to Increased Stroke Risk: Study 3Health News:Study: For a better workday, smile like you mean it 2
ROC XS is a polyethylene implant used for soft tissue reattachment to bone. The umbrella-like deployment of this anchor provides increased fixation strength. This anchor is easy-to-insert using the R...
... The Rotator Cuff Anchor (RCA), ... for soft tissue reattachment to bone. ... which eliminates the need to predrill ... in fixation is due to subcortical ...
... The Linvatec 5mm Super Revo Suture ... for arthroscopic or a mini-open rotator cuff ... and the anchor is pre-threaded with two ... potential pitfalls of suture management are avoided ...
... the standard measurement procedure to ... operations in just one step. ... Start button, the R-F10 automatically ... steps for both eyes: alignment, ...
Medicine Products: